Newer Drugs Not Cost-Effective for First-Line Diabetes Therapy ...Middle East

Costs of SGLT2 inhibitors and GLP-1 receptor agonists 'need to be lowered substantially' to improve health outcomes and prevent health disparities in patients with type 2 diabetes, say researchers. Medscape Medical News

Hence then, the article about newer drugs not cost effective for first line diabetes therapy was published today ( Tuesday 04/10/2022 - 05:04 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Newer Drugs Not Cost-Effective for First-Line Diabetes Therapy )

Also on site :

• Kevin Warsh’s first big press conference shines a spotlight on confusion over how the Fed actually measures inflation
• Lindsay Lohan Reflects on Nearly 30 Years of 'The Parent Trap'—And How It Still Resonates Today (Exclusive)
• 1975 AM Radio Gold Song, Written on a Road Trip, Was a Career-Defining Hit For John Denver